Neuromedin C (trifluoroacetate salt)

Neuromedin C (trifluoroacetate salt)

CAT N°: 24706
Price:

313.00 266.05

Neuromedin C is a bombesin-like neuropeptide that stimulates uterine smooth muscle contraction and the release of gastrin (Item No. 24457), somatostatin, and amylase in rats.{40771,40772} Neuromedin C is a truncated form of gastrin-releasing peptide (GRP; Item Nos. 24415 | 24455) corresponding to the GRP amino acids 18-27. It inhibits GRP and bombesin (Item No. 24151) binding to rat pancreatic membranes (IC50s = 0.4 and 2.2 nM, respectively), which can be reduced by sodium chloride and guanylyl imidodiphosphate (Item No. 16880).{40772} Neuromedin C induces scratching and mast cell degranulation in mice when administered intradermally at doses ranging from 1 to 300 nmol/site, which is inhibited by the BB2 bombesin receptor agonist RC-3095 and reduced in mast cell-deficient mice.{40773} Neuromedin C (3.2 nmol/kg, i.p.) reduces rat glucose consumption by approximately 50% for up to one hour.{40774}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 7-L-histidine-5-14-bombesin
  • Correlated keywords
    • 97762-70-4 81608-30-2 RC3095 GRP-10 GRP10 NMC Glycyl-L-asparaginyl-L-histidyl-L-tryptophyl-L-alanyl-L-valylglycyl-L-histidyl-L-leucyl-L-methioninamide BB-2
  • Product Overview:
    Neuromedin C is a bombesin-like neuropeptide that stimulates uterine smooth muscle contraction and the release of gastrin (Item No. 24457), somatostatin, and amylase in rats.{40771,40772} Neuromedin C is a truncated form of gastrin-releasing peptide (GRP; Item Nos. 24415 | 24455) corresponding to the GRP amino acids 18-27. It inhibits GRP and bombesin (Item No. 24151) binding to rat pancreatic membranes (IC50s = 0.4 and 2.2 nM, respectively), which can be reduced by sodium chloride and guanylyl imidodiphosphate (Item No. 16880).{40772} Neuromedin C induces scratching and mast cell degranulation in mice when administered intradermally at doses ranging from 1 to 300 nmol/site, which is inhibited by the BB2 bombesin receptor agonist RC-3095 and reduced in mast cell-deficient mice.{40773} Neuromedin C (3.2 nmol/kg, i.p.) reduces rat glucose consumption by approximately 50% for up to one hour.{40774}

We also advise you